- 著者
- 
             
             Akihiro Karube
             
             Fumiko Saito
             
             Enami Nakamura
             
             Akihiro Shitara
             
             Natsuki Ono
             
             Megumi Konno
             
             Daisuke Tamura
             
             Daisuke Nagao
             
          
- 出版者
- THE JAPANESE ASSOCIATION OF RURAL MEDICINE
- 雑誌
- Journal of Rural Medicine (ISSN:1880487X)
- 巻号頁・発行日
- vol.14, no.1, pp.48-57, 2019 (Released:2019-05-30)
- 参考文献数
- 34
- 被引用文献数
- 
             
             9
             
             
             15
             
             
          
        
        Objective: Human papillomavirus (HPV) vaccination was introduced in Japan in          April 2013, as a national immunization program for girls aged 12–16 years, after an          initial introduction in 2010 as a public-aid program for girls aged 13–16 years. The          Yuri-Honjo district had the highest vaccine coverage among women aged 17–51 years in 2017,          due to the original public-aid program. The aim of this study was to evaluate the          differences in the vaccine types of HPV16/18 infections between 2008–2012 (pre-vaccine          era) and 2013–2017 (vaccine era).Materials and Methods: We evaluated whether HPV vaccination was associated          with a decrease in the prevalence of HPV16/18 and high-risk HPV and the incidence of          HPV-associated cervical lesions. A total of 1,342 women aged 18–49 years, covering both          the pre-vaccine and vaccine eras, who visited Yuri Kumiai General Hospital and underwent          HPV genotype tests from June 2008 to December 2017 were compared.Results: Among women aged 18–24 years with higher vaccine coverage (68.2%),          the prevalence of HPV16/18 and high-risk HPV decreased from 36.7% and 69.4%, respectively,          in the pre-vaccine era to 5.8% and 50.0%, respectively, in the vaccine era (p=0.00013 and          p=0.047, respectively). Among those with cervical intraepithelial neoplasia grade 2− and          grade 2+, HPV16/18 prevalence decreased from 30.0% to 2.7% (p=0.0018) and from 81.8% to          36.4% (p=0.030), respectively. In this age group, the rate of HPV16/18 positivity          decreased significantly. Among age groups with lower vaccine coverage, HPV prevalence did          not significantly differ between the two eras.Conclusion: The prevalence of HPV16/18 and high-risk HPV significantly          decreased in women aged 18–24 years, most of whom were vaccinated. HPV vaccination          effectively reduced the prevalence of HPV16/18 infections in the Yuri-Honjo district.